Discover the most recent news about our Company.
Background: Heart failure with preserved ejection fraction (HFpEF) is a disorder related to patient comorbidities and aging. Whether mitochondrial dysfunction is
The role of inflammation in heart failure (HF) has been extensively described, but it is uncertain whether inflammation exerts a
Abstract Objective: Vascular aging (arterial stiffness [AS]) is an inflammation-linked process that predicts macro- and microvascular complications in adults with type
Biosfer Teslab desenvolupa el Test MetBalance: una innovadora anàlisi de sang per a monitoritzar la salut metabòlica i revolucionar la
Biosfer Teslab develops MetBalance Test: an innovative blood test to monitor metabolic health and revolutionize the way you take care
Objective chronic inflammation and immune dysregulation are crucial mechanisms for atherosclerosis in rheumatoid arthritis (RA). Recent evidence suggests a link
Biosfer Teslab again in Circulation Biosfer Teslab’s R&D activity is continuous, not only in terms of optimisation and development of
Background and Aims : Patients with type 2 diabetes mellitus (T2DM) and atherogenic dyslipidaemia (AD) are at higher risk of
Background and Aims : Nuclear magnetic resonance (1H-NMR) analysis have recently used to uncover hidden quantitative lipoprotein characteristics in cardiometabolic
Addressing factors modulating COVID-19 is crucial since abundant clinical evidence shows that outcomes are markedly heterogeneous between patients. This requires
Background: Atherosclerotic cardiovascular disease is the main cause of mortality worldwide and is strongly influenced by circulating low-density lipoprotein (LDL)
Treball final de grau a Biosfer Teslab Cada any a Biosfer Teslab, tenim la sort de comptar amb estudiants que
